Marshall Wace’s CervoMed CRVO Stock Holding History

Marshall Wace’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-12,017	Closed	-$75.6K	–	2963
2025 Q2	$75.6K	Buy	+12,017	New	+$102K	﹤0.01%	2569
2024 Q4	–	Sell	-11,657	Closed	-$170K	–	2641
2024 Q3	$170K	Buy	+11,657	New	+$181K	﹤0.01%	2314

Other funds holding CRVO

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

CFG

Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return

PWM

Perigon Wealth Management San Francisco, California $6.36B AUM 28.76% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

Marshall Wace's CRVO Position: Q3 2025 in Review

Marshall Wace sold out of CervoMed (CRVO) in Q3 2025, closing a stake of 12,017 shares — an estimated $75.6K sold.

Marshall Wace first reported a position in CRVO in Q3 2024 and held it in 2 quarters. The position peaked at $170K in Q3 2024. 45 funds tracked by Wall St. Rank hold CRVO as of Q3 2025.

Marshall Wace reported no remaining CervoMed position as of Q3 2025 after selling out during the quarter.
Marshall Wace sold 12,017 CervoMed shares in Q3 2025, an estimated $75.6K.
Marshall Wace first reported a position in CervoMed in Q3 2024 and held it in 2 quarters.
Marshall Wace's CervoMed position peaked at $170K in Q3 2024.
45 funds tracked by Wall St. Rank held CervoMed as of Q3 2025.

Based on Marshall Wace's 13F filing for Q3 2025, filed 13 Nov 2025.